FKBP1A
FKBP1A (FKBP prolyl isomerase 1A, also known as FKBP-12 or FKBP12) is a peptidyl-prolyl cis-trans isomerase of the immunophilin family. It accelerates protein folding and restrains signalling by TGF-beta superfamily receptors. Browse Assay Genie's current range of FKBP1A research reagents below, or read on for the biology behind the target.
FKBP1A is a peptidyl-prolyl isomerase (PPIase). PPIases accelerate the folding of proteins, and FKBP1A does this by catalysing the cis-trans isomerisation of proline imidic peptide bonds in oligopeptides. Beyond its catalytic role, it acts as a regulatory partner for several signalling proteins. It keeps the TGF-beta type I serine/threonine kinase receptor TGFBR1 in an inactive conformation, which prevents receptor activation when ligand is absent. It also recruits SMAD7 to ACVR1B, which stops SMAD2 and SMAD3 associating with the activin receptor complex and so blocks the activin signal.
FKBP1A is a member of the immunophilin protein family, which has roles in immunoregulation and in basic cellular processes such as protein folding and trafficking. The protein binds the immunosuppressants FK506 and rapamycin. It also interacts with intracellular calcium release channels and coordinates formation of the multi-protein complex of the tetrameric skeletal muscle ryanodine receptor. UniProt notes that it may modulate RYR1 calcium channel activity. The protein is found in the cytosol and at the sarcoplasmic reticulum membrane. The FKBP1A gene is alternatively spliced, and the variants encode the same protein. The human genome also contains five related pseudogenes, at least one of which is transcribed.
The protein belongs to the FKBP-type PPIase family, FKBP1 subfamily. Its older names, FK506-binding protein 1A (12kD) and FKBP12, reflect its affinity for FK506 and its approximate size. In mouse, deletion of the homologous gene causes a congenital heart disorder, noncompaction of left ventricular myocardium. HGNC also lists FKBP1A among the microRNA protein coding host genes.
FKBP1A holds TGFBR1 inactive without ligand and helps block activin signalling through SMAD7 recruitment to ACVR1B.
It interacts with intracellular calcium release channels and coordinates assembly of the tetrameric skeletal muscle ryanodine receptor complex.
As an immunophilin that binds FK506 and rapamycin, FKBP1A is central to work on immunoregulation by these drugs.
Its prolyl isomerase activity supports protein folding, and loss of the mouse gene causes left ventricular noncompaction.
FKBP1A is a cis-trans prolyl isomerase that accelerates protein folding. It also keeps TGFBR1 inactive without ligand, recruits SMAD7 to ACVR1B to block activin signalling, and may modulate RYR1 calcium channel activity. It binds FK506 and rapamycin.
FKBP1A is also called FKBP-12, FKBP12, PKC12, PPIASE, FKBP12C and FKBP1. Earlier names include FK506-binding protein 1A (12kD). Alternatively spliced transcript variants have been identified, and all of them encode the same protein.
Mouse and rat both have an Fkbp1a ortholog. In mouse, deleting the homologous gene causes noncompaction of left ventricular myocardium, a congenital heart disorder. Check the datasheet of any product for its validated reactivity.
Other FKBP family prolyl isomerases and immunophilins that are related to FKBP1A.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P62942; product specifications from Assay Genie datasheets.